» Articles » PMID: 27126886

The Effect of Glycemic Status on Kidney Stone Disease in Patients with Prediabetes

Overview
Specialty Endocrinology
Date 2016 Apr 30
PMID 27126886
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: While the evidence supporting a positive association between diabetes mellitus and kidney stone disease (KSD) is solid, studies examining the association between impaired fasting glucose (IFG) and KSD show inconsistent results. Currently, there are no studies examining the relationship between impaired glucose tolerance (IGT) and KSD. The objective of this study is to investigate the effects of different glycemic statuses on KSD. The results may help to motivate patients with diabetes to conform to treatment regimens.

Methods: We conducted a cross sectional study of a population that underwent health check-ups between January 2000 and August 2009 at the Health Evaluation Center of National Cheng Kung University Hospital. A total of 14,186 subjects were enrolled. The following categories of glycemic status were used according to the criteria of the 2009 American Diabetes Association: normal glucose tolerance, isolated IGT, isolated IFG, combined IFG/IGT, and diabetes. The existence of KSD was evaluated using renal ultrasonography, and the presence of any hyperechoic structures causing acoustic shadowing was considered to be indicative of KSD.

Results: The prevalence of KSD was 7.4% (712/9,621), 9.3% (163/1,755), 10.8% (78/719), 12.0% (66/548), and 11.3% (174/1,543) in subjects with NGT, isolated IGT, isolated IFG, combined IFG/IGT, and diabetes, respectively. Isolated IFG, combined IFG/IGT, and diabetes were associated with KSD after adjusting for other clinical variables, but isolated IGT was not. Age (41 to 64 years vs. ≤40 years, ≥65 years vs. ≤40 years), male gender, hypertension, and hyperuricemia were also independently associated with KSD.

Conclusion: Isolated IFG, combined IFG/IGT, and diabetes, but not isolated IGT, were associated with a higher risk of KSD.

Citing Articles

Nephrolithiasis: A Red Flag for Cardiovascular Risk.

Gambaro A, Lombardi G, Caletti C, Ribichini F, Ferraro P, Gambaro G J Clin Med. 2022; 11(19).

PMID: 36233380 PMC: 9573143. DOI: 10.3390/jcm11195512.


Association between metabolic syndrome components and the risk of developing nephrolithiasis: A systematic review and bayesian meta-analysis.

Rahman I, Nusaly I, Syahrir S, Nusaly H, Mansyur M F1000Res. 2021; 10:104.

PMID: 34804491 PMC: 8577060. DOI: 10.12688/f1000research.28346.1.


Urolithiasis: Prevalence, risk factors, and public awareness regarding dietary and lifestyle habits in Jeddah, Saudi Arabia in 2017.

Baatiah N, Alhazmi R, Albathi F, Albogami E, Mohammedkhalil A, Alsaywid B Urol Ann. 2020; 12(1):57-62.

PMID: 32015619 PMC: 6978981. DOI: 10.4103/UA.UA_13_19.


Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences.

Spatola L, Angelini C, Badalamenti S, Maringhini S, Gambaro G Urolithiasis. 2016; 45(5):457-460.

PMID: 27921141 DOI: 10.1007/s00240-016-0956-8.

References
1.
Kim Y, Kim C, Sung E, Kim S, Shin H, Jung W . Association of nephrolithiasis with metabolic syndrome and its components. Metabolism. 2013; 62(6):808-13. DOI: 10.1016/j.metabol.2012.12.010. View

2.
Cook D, Shaper A, Thelle D, Whitehead T . Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J. 1986; 62(733):1001-6. PMC: 2418956. DOI: 10.1136/pgmj.62.733.1001. View

3.
Lieske J, de la Vega L, Gettman M, Slezak J, Bergstralh E, Melton 3rd L . Diabetes mellitus and the risk of urinary tract stones: a population-based case-control study. Am J Kidney Dis. 2006; 48(6):897-904. DOI: 10.1053/j.ajkd.2006.09.002. View

4.
Rendina D, Mossetti G, DE Filippo G, Benvenuto D, Vivona C, Imbroinise A . Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant. 2008; 24(3):900-6. DOI: 10.1093/ndt/gfn548. View

5.
Sakhaee K, Maalouf N, Sinnott B . Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab. 2012; 97(6):1847-60. PMC: 3387413. DOI: 10.1210/jc.2011-3492. View